5D Library › Books › 5DL-B-096
复合补剂相互作用、时间疗法给药窗口与代谢酶竞争
米氏抑制矩阵、肠道螯合损耗与昼夜受体敏感度
Polypharmacy Supplement Interactions, Chronotherapy Dosing Windows and Cytochrome Enzyme Competition: Michaelis-Menten Inhibition Matrices, Chelation Absorption Losses and Circadian Receptor Sensitivity
DOI10.5281/zenodo.24090250摘要
一把胶囊同时吞下,到底损失了多少?把它们分成几堆、分别在什么时辰吃,又能收回多少?本书把这些问题写成可以运行的算术,再看答案在什么条件下成立。书中参数均为示意或合成;全部数字由书中程序产生;本书不是医疗建议,不作诊断,也不可用于开始、停止或改动任何补剂或药物。
第一章从米氏方程出发:一个与底物等量的竞争者,在底物只有亲和常数十分之一时夺去 0.4762 的速率,而在底物为其五倍时只夺去 0.1429,相差 3.33 倍,所以可饱和位点恰在剂量小处最脆弱。十一种常见补剂的矩阵显示,同服时七项的损失超过百分之一,被打击最重的钙损失 0.7537,锌损失 0.7498,唯一的获益者姜黄素增加 0.5560。第二章给出共享载体的一条恒等式:新的竞争者把同一位点上每个既有占位者的吸收乘以完全相同的因子,所以使铁吸收减半与使锌吸收减半的钙剂量同为 573.3 毫克;而在钙 500 与镁 400 毫克之下,铁只保住 0.5341。腔内损耗另算:质子泵抑制剂使铁的 pH 项损失 0.6697,铁溶解度减半的胃内 pH 为 3.826。
第三章把位点竞争与肠道条件相乘:一把同吞的损失为 0.5096,其中八项损失至少 0.35,最重的铁只留下 0.0856。第四章在一分钟的网格上定出最佳时刻:晨间辅因子在 04:32,夜间镇静剂在 23:42,相位差 19.17 小时即 287.5 度;六小时的偏差分别损失 0.6156 与 0.7652。第五章显示咖啡因半衰期在最快与最慢两种状态间差 7.50 倍,14:00 一杯在最慢状态下使入睡时间从 18.4 分钟升到 40.5 分钟;代谢抑制的暴露倍数被一除以一减清除分数所封顶。
第六章穷举 177147 种三槽排程,最优为 0.8605,而全部放进早餐为 0.5394;更要紧的是 0.8355 的随意排程比全部放进早餐更差。第七章把《神农本草经》七情和合写成矩阵:55 对中 47 对各行其是,7 对相反,1 对相使;并把《本草纲目》序例所引服药时辰的四条规则与算术对照,四条全合,而本书指出这个一致性来自作者自己的对应方式。第八章显示依从性把三槽排程从 0.8605 拉到 0.7362,而安全闸拦下或转诊 0.5363 的成年人。书中以标注框区分已发表的证据、可运行的 Python 计算(十六段程序)、原典与作者的假说。
关键词:补剂相互作用;复方同服;米氏动力学;竞争性抑制;抑制矩阵;二价金属转运体;铁吸收;锌吸收;钙干扰;植酸;多酚;胃内酸度;质子泵抑制剂;螯合;生物利用度;胡椒碱;姜黄素;时间药理学;时间疗法;给药窗口;相位反应;皮质醇;褪黑素;昼夜节律;细胞色素P450;咖啡因半衰期;入睡潜伏期;药物相互作用方程;排程;组合优化;依从性;神农本草经;七情和合;李时珍
Abstract
How much does a handful of capsules swallowed at once actually lose? And how much can be recovered by splitting them into groups taken at different hours? This book writes these questions as runnable arithmetic and then asks when the answers hold. Its parameters are illustrative or synthetic; all figures are produced by the programs printed in the book; the book is not medical advice, does not diagnose, and must not be used to start, stop or change any supplement or medicine.
Chapter 1 starts from the Michaelis equation: a competitor present at its own inhibition constant takes 0.4762 of the rate when the substrate is a tenth of the affinity constant but only 0.1429 when it is five times that constant, a ratio of 3.33, so a saturable site is weakest exactly where the dose is small. A matrix of eleven common items shows seven losing more than one part in a hundred when taken together, with calcium worst hit at 0.7537 and zinc at 0.7498, while curcumin is the one gainer at 0.5560. Chapter 2 proves an identity about a shared carrier: a new competitor multiplies every existing occupant's absorption by exactly the same factor, so the calcium dose that halves iron absorption and the one that halves zinc absorption are both 573.3 mg; at calcium 500 and magnesium 400 mg, iron keeps only 0.5341. Losses inside the gut lumen are separate: a proton pump inhibitor costs iron 0.6697 through the pH term alone, and iron solubility halves at a stomach pH of 3.826.
Chapter 3 multiplies site competition by gut condition: the handful loses 0.5096, eight of eleven items lose at least 0.35, and iron keeps only 0.0856. Chapter 4 locates the best moment on a one-minute grid: 04:32 for a morning cofactor and 23:42 for an evening calmer, a phase difference of 19.17 hours or 287.5 degrees, with a six-hour error costing 0.6156 and 0.7652. Chapter 5 shows the caffeine half-life differing by 7.50 times between the fastest and slowest states, so that one cup at 14:00 raises sleep onset from 18.4 to 40.5 minutes in the slowest, and shows the exposure multiplier of metabolic inhibition bounded by one over one minus the cleared fraction.
Chapter 6 enumerates all 177147 three-slot schedules: the optimum scores 0.8605 against 0.5394 for everything at breakfast, and, more to the point, 0.8355 of arbitrary schedules are worse than everything at breakfast. Chapter 7 writes the seven relations of the Shennong pharmacopoeia as a matrix, finding 47 of the 55 pairs acting alone, 7 in opposition and 1 assisting, and compares the four dosing-hour rules quoted in the preface to the Bencao gangmu with the arithmetic, which agrees on all four while the book argues that the agreement comes from the author's own mapping. Chapter 8 shows adherence pulling the three-slot schedule from 0.8605 down to 0.7362, and the safety gate stopping or referring 0.5363 of adults. Marked boxes separate published evidence, runnable Python calculations (sixteen programs), classical sources and the author's hypotheses.
Keywords: supplement interactions; polypharmacy; Michaelis-Menten kinetics; competitive inhibition; inhibition matrix; divalent metal transporter; iron absorption; zinc absorption; calcium interference; phytate; polyphenols; gastric pH; proton pump inhibitor; chelation; bioavailability; piperine; curcumin; chronopharmacology; chronotherapy; dosing window; phase response; cortisol; melatonin; circadian rhythm; cytochrome P450; CYP1A2; CYP3A4; caffeine half-life; sleep onset latency; drug interaction equation; scheduling; combinatorial optimisation; adherence; Shennong pharmacopoeia; seven relations; Li Shizhen
目录 · Contents
- 序:一把胶囊,以及它的代价English 中文Preface: A Handful, and What It Costs
- 第一章 可饱和位点上的竞争English 中文Chapter 1. Competition at a Saturable Site
- 第二章 一个载体,以及它之前的损耗English 中文Chapter 2. One Carrier, and the Losses Before It
- 第三章 那一把English 中文Chapter 3. The Handful
- 第四章 受体在听的时候English 中文Chapter 4. When the Receptor Is Listening
- 第五章 肝脏里的两个酶English 中文Chapter 5. Two Enzymes in the Liver
- 第六章 精确解出的排程English 中文Chapter 6. The Schedule, Solved Exactly
- 第七章 七情和合English 中文Chapter 7. The Seven Relations
- 第八章 依从性,以及那道闸English 中文Chapter 8. Adherence, and the Gate
How to cite · 引用
Fan, Y. (2026). Polypharmacy Supplement Interactions, Chronotherapy Dosing Windows and Cytochrome Enzyme Competition: Michaelis-Menten Inhibition Matrices, Chelation Absorption Losses and Circadian Receptor Sensitivity [复合补剂相互作用、时间疗法给药窗口与代谢酶竞争] (Version 1.0.0). 5D Library. https://doi.org/10.5281/zenodo.24090250
BibTeX
@book{fan2026polypharmacy,
title = {{Polypharmacy Supplement Interactions, Chronotherapy Dosing Windows and Cytochrome Enzyme Competition}: Michaelis-Menten Inhibition Matrices, Chelation Absorption Losses and Circadian Receptor Sensitivity},
author = {Fan, Yafu},
year = {2026},
publisher = {5D Library},
edition = {Version 1.0.0},
doi = {10.5281/zenodo.24090250},
url = {https://doi.org/10.5281/zenodo.24090250},
note = {Chinese title: 复合补剂相互作用、时间疗法给药窗口与代谢酶竞争}
}
| DOI | https://doi.org/10.5281/zenodo.24090250 |
|---|---|
| DOI(全部版本 all versions) | https://doi.org/10.5281/zenodo.24090249 |
| ORCID | https://orcid.org/0009-0004-3519-1203 |
| 5D Library ID | 5DL-B-096 |
| 版本 Version | 1.0.0 · 中英双语版 Bilingual edition |
| 出版日期 Date | 2026-11-09 |
| 网址 Online | https://5dlibrary.com/books/polypharmacy-supplement-interactions-chronotherapy-windows-enzyme-competition/ |
| SHA-256 · polypharmacy-supplement-interactions-chronotherapy-windows-enzyme-competition_bilingual_v1.0.0.pdf | a033d44686ad0b7411daabf7aa14dfb105a7bf21f77dfe1e74eea66840c9753d |
| SHA-256 · polypharmacy-supplement-interactions-chronotherapy-windows-enzyme-competition_en_v1.0.0.pdf | dc29140fff6c6bbc6473a57e5b2c4be82bef14878b6cab1bbd39ca8bb46cd283 |
| SHA-256 · polypharmacy-supplement-interactions-chronotherapy-windows-enzyme-competition_zh_v1.0.0.pdf | 7f214b83c234c14f362761c0dcd71b69e315a1da4ceeb0e3bd0a270e494b0dae |
| Licence · 许可 | Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Disclosure. The author uses the works of 5D Library, including this book, as the methodological basis of his community courses, the 5D Ascension Cards (Dimensional Shift Card Decks) and the Yafu AI knowledge base, and runs a number of websites, paid online calculators, subscriptions, reports, courses, business licences and advisory services, including content on metabolic health, supplements and biohacking, which is exactly what this book studies, so he has a direct commercial interest in its subject. The book promotes no software, course, card deck, supplement or service, uses no client's health data, and accepts no sponsorship from any supplement or pharmaceutical company. Its parameters are synthetic or illustrative. This book is not medical advice, does not diagnose, and must not be used to start, stop or change any supplement or medicine. The hypotheses of Chapters 1 to 8 must be tested under pre-registered protocols, and the results published whether positive or negative.